Education
About Us
Working with TipRanks
Follow Us
FluoGuide A/S (SE:FLUO)
:FLUO
FLUO Stock Chart & Stats
Day’s Range― - ―
52-Week Rangekr29.10 - kr57.00
Previous CloseN/A
Volume5.01K
Average Volume (3M)6.69K
Market Cap
kr548.89M
Enterprise Valuekr555.06M
Total Cash (Recent Filing)kr19.63M
Total Debt (Recent Filing)kr22.83M
Price to Earnings (P/E)―
Beta0.43
Next Earnings
Nov 27, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.96
Shares Outstanding13,620,149
10 Day Avg. Volume4,500
30 Day Avg. Volume6,688
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
kr38.00Price Target Upside-4.76% Downside
Rating ConsensusHold
Number of Analyst Covering0
FLUO FAQ
What was FluoGuide A/S’s price range in the past 12 months?
FluoGuide A/S lowest stock price was kr29.10 and its highest was kr57.00 in the past 12 months.
What is FluoGuide A/S’s market cap?
FluoGuide A/S’s market cap is kr548.89M.
When is FluoGuide A/S’s upcoming earnings report date?
FluoGuide A/S’s upcoming earnings report date is Nov 27, 2025 which is in 82 days.
How were FluoGuide A/S’s earnings last quarter?
FluoGuide A/S released its earnings results on Aug 28, 2025. The company reported -kr0.965 earnings per share for the quarter, missing the consensus estimate of N/A by -kr0.965.
Is FluoGuide A/S overvalued?
According to Wall Street analysts FluoGuide A/S’s price is currently Overvalued.
Does FluoGuide A/S pay dividends?
FluoGuide A/S does not currently pay dividends.
What is FluoGuide A/S’s EPS estimate?
FluoGuide A/S’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does FluoGuide A/S have?
FluoGuide A/S has 13,620,149 shares outstanding.
What happened to FluoGuide A/S’s price movement after its last earnings report?
FluoGuide A/S reported an EPS of -kr0.965 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 3.807%.
Which hedge fund is a major shareholder of FluoGuide A/S?
Currently, no hedge funds are holding shares in SE:FLUO
Company Description
FluoGuide A/S
FluoGuide A/S, a life science company, engages in the development and sale of surgical solutions in Denmark. Its lead product candidate is FG001, which is in Phase I/II for the treatment of high-grade glioma, as well as Phase II clinical trial for the treatment of lung cancer. The company also develops FG002, which is in preclinical stage that allows surgeons to differentiate cancer from normal tissue during surgery through a novel uPAR-targeted luminescent technology. FluoGuide A/S has an agreement with Linköping University Hospital for the development of FG001 that is in the Phase I/II clinical trial for surgical removal of brain cancer; and a collaboration with Copenhagen University Hospital. The company was incorporated in 2018 and is headquartered in Copenhagen, Denmark.
Technical Analysis
Q-linea AB
―
Ascelia Pharma AB
―
IRLAB Therapeutics AB Class A
―
Guard Therapeutics International AB
―
Nanexa AB
―